
Addressing Treatment Gaps in High-Risk CML in Blast Phase
While the management of chronic myeloid leukemia (CML) has evolved significantly over recent years, key challenges remain in optimizing outcomes, particularly for high-risk patients and those progressing to blast phase. “[T]here are no standardized …